PULMONARY EMBOLISM
LEARNING CENTRE
WHAT’S NEW
PULMONARY EMBOLISM
LEARNING CENTRE
WHAT’S NEW

 
Vascular Surgery / Venous Thromboembolism / Pulmonary Embolism / ESC Guidelines

 

The Diagnosis and Management of Acute Pulmonary Embolism (PE)

 

 

Although there has been significant development in our ability to prevent, diagnose and treat acute pulmonary embolism, it remains a significant cause of morbidity and mortality.1

This has been the rationale for finding new approaches and options for managing patients at intermediate and high-risk of PE. The field has been rapidly evolving, opening up new treatment options beyond standard anticoagulation.

Indeed, if PE can be diagnosed and the appropriate therapy started, the mortality can be reduced from approximately 30% to less than 5%.2,3

In 2019, the ESC updated their guidelines on the use of catheter-directed treatment as an alternative to rescue thrombolytic therapy for patients who deteriorate haemodynamically, bringing their recommendations from Class IIb to Class IIa.4

Clinical Suspicion of PE
The PE roadmap shown here is adapted from the European Society of Cardiology (ESC) Guidelines.4
 
 
Clinical Suspicion of PE


Access the ESC Guidelines on Acute Pulmonary Embolism


Boston Scientific has developed a blended learning program to help HCPs improve the management of patients with pulmonary embolism. Learn more about this program

 

 

Back to Pulmonary Embolism main page
Top